Growing community of inventors

Wako, Japan

Fumihiko Ishikawa

Average Co-Inventor Count = 3.16

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Fumihiko IshikawaYoriko Saito (3 patents)Fumihiko IshikawaOsamu Ohara (1 patent)Fumihiko IshikawaLeonard D Shultz (1 patent)Fumihiko IshikawaYasuko Koda (1 patent)Fumihiko IshikawaHitomi Yuki (1 patent)Fumihiko IshikawaYoshinobu Hashizume (1 patent)Fumihiko IshikawaHiroshi Kitamura (0 patent)Fumihiko IshikawaHidetoshi Ozawa (0 patent)Fumihiko IshikawaAtsushi Hijikata (0 patent)Fumihiko IshikawaFumihiko Ishikawa (3 patents)Yoriko SaitoYoriko Saito (3 patents)Osamu OharaOsamu Ohara (26 patents)Leonard D ShultzLeonard D Shultz (9 patents)Yasuko KodaYasuko Koda (2 patents)Hitomi YukiHitomi Yuki (2 patents)Yoshinobu HashizumeYoshinobu Hashizume (2 patents)Hiroshi KitamuraHiroshi Kitamura (0 patent)Hidetoshi OzawaHidetoshi Ozawa (0 patent)Atsushi HijikataAtsushi Hijikata (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Riken Corporation (3 from 854 patents)

2. The Jackson Laboratory (1 from 90 patents)


3 patents:

1. 10278979 - Therapeutic agent for intractable leukemia

2. 9604988 - Agent for treating or inhibiting recurrence of acute myeloid leukemia

3. 9125384 - Mouse having human leukemic stem cell and leukemic non-stem cell amplified therein, and method for production thereof

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/19/2025
Loading…